Single human T cells stimulated in the absence of feeder cells transcribe interleukin-2 and undergo long-term clonal growth in response to defined monoclonal antibodies and cytokine stimulation

Blood. 1996 Jun 15;87(12):5179-84.

Abstract

The two-signal model of T-cell activation postulates that T lymphocytes require at least two distinct signals for activation. This model has been established with bulk cultures of T cells in which T-cell-T-cell interaction can occur, possibly delivering further unrecognized costimulatory signals. The signal requirements of single T cells for the induction of clonal cell growth or the transcription of cytokines would best be studied in a cell cloning system in the absence of feeder cells; however, such an experimental system has not been reported so far. In this study, we report the long-term cloning of human resting peripheral blood CD4+CD45RO- T cells under feeder cell-free conditions in response to CD3 and CD28 stimulation in the presence of exogenous interleukin-2 (IL-2). Cloning efficiency ranged from 40% to 60% depending on the presence of additional cytokines IL-1 and IL-6. Single-call polymerase chain reaction showed that transcription of IL-2 occurred in cells stimulated through CD3 plus CD28 alone. T cells grown in response to CD3 plus CD28 plus IL-2 stimulation produced both IL-4 and interferon-gamma (IFN-gamma) on restimulation (Th0 cells) and could be functionally differentiated into Th1- or Th2-type cells by the addition of IFN-gamma or IL-4, respectively, during cell cloning. These data show on the single-cell level a two-signal model of T- cell activation for the transcription of IL-2. In addition, these experiments show that IFN-gamma and IL-4 exert their T-cell-differentiating effects directly on the T cell without any further need for antigen-presenting cells. Together, our experiments show the feasability of a defined long-term clonal cell culture system to study the growth and differentiation of human T lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / pharmacology*
  • Base Sequence
  • CD28 Antigens / immunology
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology*
  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Cells, Cultured
  • Clone Cells
  • Cytokines / immunology
  • Cytokines / pharmacology*
  • Gene Expression Regulation / drug effects
  • Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
  • Humans
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / pharmacology
  • Interleukin-1 / pharmacology
  • Interleukin-2 / biosynthesis*
  • Interleukin-2 / genetics
  • Interleukin-2 / pharmacology
  • Interleukin-4 / biosynthesis
  • Interleukin-4 / pharmacology
  • Interleukin-6 / pharmacology
  • Lymphocyte Activation / drug effects*
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • Receptor-CD3 Complex, Antigen, T-Cell / immunology
  • Th1 Cells / cytology
  • Th2 Cells / cytology

Substances

  • Antibodies, Monoclonal
  • CD28 Antigens
  • Cytokines
  • Interleukin-1
  • Interleukin-2
  • Interleukin-6
  • Receptor-CD3 Complex, Antigen, T-Cell
  • Interleukin-4
  • Interferon-gamma